PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Researchers provide rationale for use of targeted immunotherapy in sarcomatoid lung carcinomas

Find higher levels of programmed death ligand-1 in rare disease

2013-05-28
(Press-News.org) DENVER – Sarcomatoid carcinomas of the lung include rare subtypes of poorly differentiated non–small-cell lung carcinomas of high grade and aggressive behavior. The biology of these neoplasms is poorly understood and these tumors are aggressive and resistant to chemotherapy and radiotherapy. The identification of actionable molecular targets for such infrequent and aggressive diseases is critical for design of new clinical trials. Programmed death-1 (PD-1) is a co-inhibitory inducible receptor present on T-cells and macrophages. Tumor cells with increased programmed death ligand-1 (PD-L1) are believed to escape immunity through activation of PD-1/PD-L1 pathway and suppression of effector-immune responses. Researchers at the Yale School of Medicine measured the levels of the PD-L1 protein in sarcomatoid carcinomas. In a recent study published in the Journal of Thoracic Oncology (JTO), the results show that SCs show higher PD-L1 levels than other NSCLC, supporting a potential for the use of anti-PD-1/PD-L1 targeted therapies. The study says, "despite the presence of rich inflammatory infiltrates patients with SCs have worse outcomes compared with other histologic subtypes of NSCLC. Elevated expression of PD-L1 by SC cells might account for this apparent contradiction because local inactivation of effector-immune cells through PD-1 receptor signaling could ultimately enhance the disease progression." The researchers, "suggest the possibility of using novel immunotherapy approaches such as PD-1/PD-L1 blockers in this otherwise difficult to treat disease."

### About the IASLC: The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated to the study of lung cancer. Founded in 1974, the association's membership includes more than 3,500 lung cancer specialists in 80 countries. To learn more about IASLC please visit http://www.iaslc.org.


ELSE PRESS RELEASES FROM THIS DATE:

Beer-pouring robot programmed to anticipate human actions

2013-05-28
ITHACA, N.Y. – A robot in Cornell's Personal Robotics Lab has learned to foresee human action in order to step in and offer a helping hand, or more accurately, roll in and offer a helping claw. Video: https://www.youtube.com/watch?v=xaa_wEkCvG0 Understanding when and where to pour a beer or knowing when to offer assistance opening a refrigerator door can be difficult for a robot because of the many variables it encounters while assessing the situation. A team from Cornell has created a solution. Gazing intently with a Microsoft Kinect 3-D camera and using a database ...

New ruthenium complexes target cancer cells without typical side effects

2013-05-28
A team of UT Arlington researchers has identified two ruthenium-based complexes they believe could pave the way for treatments that control cancer cell growth more effectively and are less toxic for patients than current chemotherapies. Fred MacDonnell, professor of chemistry and biochemistry at The University of Texas at Arlington, has been researching a new generation of metal-based antitumor agents along with a team from the City of Hope Comprehensive Center Center in Duarte, Calif. Their aim is to find new therapies to complement widely used platinum-based therapies, ...

Shape-shifting nanoparticles flip from sphere to net in response to tumor signal

2013-05-28
Scientists at the University of California, San Diego, have designed tiny spherical particles to float easily through the bloodstream after injection, then assemble into a durable scaffold within diseased tissue. An enzyme produced by a specific type of tumor can trigger the transformation of the spheres into netlike structures that accumulate at the site of a cancer, the team reports in the journal Advanced Materials this week. Targeting treatments specifically to cancerous or other diseased cells depends on some means of accumulating high levels of a drug or other therapeutic ...

For pundits, it's better to be confident than correct

2013-05-28
PULLMAN, Wash. - It would be nice to think the pundits we see yelling on TV and squawking on Twitter are right all the time. It turns out they're wrong more often than they are right. Now two Washington State University economics students have demonstrated that it simply doesn't pay as much for a pundit to be accurate as it does to be confident. It's one thing to be a good pundit, but another to be popular. "In a perfect world, you want to be accurate and confident," says Jadrian Wooten. "If you had to pick, being confident will get you more followers, get you more demand." Wooten ...

Saturated fats do not yield better bacon

2013-05-28
A recent paper published in the Journal of Animal Science suggests producers may want to adjust pig diets when including distillers dried grains with solubles (DDGS). Some producers believe that feeding pigs saturated fats will undo the fat-softening effects of DDGS. Firmer fat means longer-lasting pork. But researchers from the University of Illinois found that including saturated fats in DDGS diets makes no difference in fat quality. The researchers formulated six corn-soybean meal diets to test the effects of saturated fat additives on carcass fat quality in pigs. ...

Annals of Internal Medicine tip sheet for May 28, 2013

2013-05-28
1. Evidence Suggests Screening for Gestational Diabetes Can Improve Maternal and Fetal Outcomes Evidence review will inform recommendations on screening for gestational diabetes The oral glucose challenge test (OGCT) and testing for fasting plasma glucose levels may be the best way to rule out gestational diabetes mellitus (GDM) in women who are at about 24 weeks' gestation. The OGCT may be better for diagnosing women who have GDM. GDM puts babies at risk for having a high birth weight, low blood sugar, and jaundice. GDM is also associated with seizures or still birth. ...

UCI researchers find sea anemone venom-derived compound effective in anti-obesity studies

2013-05-28
Irvine, CA & Seattle, WA — Scientists at UC Irvine reported this week that a synthetic compound ShK-186, originally derived from a sea anemone toxin, has been found to enhance metabolic activity and shows potential as a treatment for obesity and insulin resistance. The findings published the week of May 27 in the Proceedings of the National Academy of Sciences reveal that ShK-186 selectively blocks the activity of a protein that promotes inflammation through the Kv1.3 potassium channel. The study presents the first evidence that the drug candidate – which in March showed ...

KISS ME DEADLY proteins may help improve crop yields

2013-05-28
Dartmouth College researchers have identified a new regulator for plant hormone signaling -- the KISS ME DEADLY family of proteins (KMDs) – that may help to improve production of fruits, vegetables and grains. The study's results will be published the week of May 27 in the journal Proceedings of the National Academy of Sciences. Journalists can access the paper, titled "SCFKMD controls cytokinin signaling by regulating the degradation of type-B response regulators," through EurekAlert!. Professor G. Eric Schaller, the paper's senior author, studies the molecular mechanisms ...

Spine function improves following cell replacement therapy with fetal human stem cells

2013-05-28
Human foetal stem cell grafts improve both motor and sensory functions in rats suffering from a spinal cord injury, according to research published this week in BioMed Central's open access journal Stem Cell Research and Therapy. This cell replacement therapy also improves the structural integrity of the spine, providing a functional relay through the injury site. The research gives hope for the treatment of spinal cord injuries in humans. Grafting human neural stem cells into the spine is a promising approach to promote the recovery of function after spinal injury. ...

Patients with end-stage kidney disease have different expectations than their doctors

2013-05-28
BOSTON – In any given year, 400,000 Americans suffering from end-stage kidney disease will undergo dialysis, and as many as 20 to 25 percent of those dialysis patients will die, a statistic comparable to many types of cancer. But while cancer doctors may be more accustomed to talking with patients about the likely course of their disease, a new study from Beth Israel Deaconess Medical Center finds that doctors who treat patients with kidney failure are reluctant to discuss a difficult prognosis, and their patients are likely to have distorted expectations about their own ...

LAST 30 PRESS RELEASES:

New strategies to enhance chiral optical signals unveiled

Cambridge research uncovers powerful virtual reality treatment for speech anxiety

2025 Gut Microbiota for Health World Summit to spotlight groundbreaking research

International survey finds that support for climate interventions is tied to being hopeful and worried about climate change

Cambridge scientist launches free VR platform that eliminates the fear of public speaking

Open-Source AI matches top proprietary model in solving tough medical cases

Good fences make good neighbors (with carnivores)

NRG Oncology trial supports radiotherapy alone following radical hysterectomy should remain the standard of care for early-stage, intermediate-risk cervical cancer

Introducing our new cohort of AGA Future Leaders

Sharks are dying at alarming rates, mostly due to fishing. Retention bans may help

Engineering excellence: Engineers with ONR ties elected to renowned scientific academy

New CRISPR-based diagnostic test detects pathogens in blood without amplification

Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer

Growing solar: Optimizing agrivoltaic systems for crops and clean energy

Scientists discover how to reactivate cancer’s molecular “kill switch”

YouTube influencers: gaming’s best friend or worst enemy?

uOttawa scientists use light to unlock secret of atoms

NJIT mathematician to help map Earth's last frontier with Navy grant

NASA atmospheric wave-studying mission releases data from first 3,000 orbits

‘Microlightning’ in water droplets may have sparked life on Earth

Smoke from wildland-urban interface fires more deadly than remote wildfires

What’s your body really worth? New AI model reveals your true biological age from 5 drops of blood

Protein accidentally lassos itself, helping explain unusual refolding behavior

With bird flu in raw milk, many in U.S. still do not know risks of consuming it

University of Minnesota research team awarded $3.8 million grant to develop cell therapy to combat Alzheimer’s disease

UConn uncovers new clue on what is leading to neurodegenerative diseases like Alzheimer’s and ALS

Resuscitation in out-of-hospital cardiac arrest – it’s how quickly it is done, rather than who does it

A closer look at biomolecular ‘silly putty’

Oxytocin system of breastfeeding affected in mothers with postnatal depression

Liquid metal-enabled synergetic cooling and charging: a leap forward for electric vehicles

[Press-News.org] Researchers provide rationale for use of targeted immunotherapy in sarcomatoid lung carcinomas
Find higher levels of programmed death ligand-1 in rare disease